Found: 81
Select item for more details and to access through your institution.
Creating a smART Camp.
- Published in:
- Science Scope, 2011, v. 35, n. 2, p. 46
- By:
- Publication type:
- Article
Phase I/II trial of pyrazoloacridine and carboplatin in patients with recurrent glioma: A North Central Cancer Treatment Group trial.
- Published in:
- Investigational New Drugs, 2005, v. 23, n. 5, p. 495, doi. 10.1007/s10637-005-2910-4
- By:
- Publication type:
- Article
Identification of a broad coverage HLA-DR degenerate epitope pool derived from carcinoembryonic antigen.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 1, p. 161, doi. 10.1007/s00262-009-0738-z
- By:
- Publication type:
- Article
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 3, p. 408, doi. 10.1002/ajh.27202
- By:
- Publication type:
- Article
Utilization of real‐world data in assessing treatment effectiveness for diffuse large B‐cell lymphoma.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 1, p. 180, doi. 10.1002/ajh.26767
- By:
- Publication type:
- Article
Anthracycline treatment, cardiovascular risk factors and the cumulative incidence of cardiovascular disease in a cohort of newly diagnosed lymphoma patients from the modern treatment era.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 8, p. 979, doi. 10.1002/ajh.26230
- By:
- Publication type:
- Article
Relapsed/Refractory International Prognostic Index (R/R‐IPI): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphoma.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 5, p. 599, doi. 10.1002/ajh.26149
- By:
- Publication type:
- Article
Testicular FDG‐PET/CT uptake threshold in aggressive lymphomas.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 3, p. E81, doi. 10.1002/ajh.26073
- By:
- Publication type:
- Article
Bortezomib consolidation or maintenance following immunochemotherapy and autologous stem cell transplantation for mantle cell lymphoma: CALGB/Alliance 50403.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 6, p. 583, doi. 10.1002/ajh.25783
- By:
- Publication type:
- Article
Detection of extranodal and spleen involvement by FDG‐PET imaging predicts adverse survival in untreated follicular lymphoma.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 7, p. 786, doi. 10.1002/ajh.25493
- By:
- Publication type:
- Article
The utility of prognostic indices, early events, and histological subtypes on predicting outcomes in non‐follicular indolent B‐cell lymphomas.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 6, p. 658, doi. 10.1002/ajh.25473
- By:
- Publication type:
- Article
Host genetic variation in tumor necrosis factor and nuclear factor‐κB pathways and overall survival in mantle cell lymphoma: A discovery and replication study.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 6, p. E153, doi. 10.1002/ajh.25451
- By:
- Publication type:
- Article
Prevalence, clinical characteristics and prognosis of EBV‐positive follicular lymphoma.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 2, p. E62, doi. 10.1002/ajh.25357
- By:
- Publication type:
- Article
The association of physical activity before and after lymphoma diagnosis with survival outcomes.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 12, p. 1543, doi. 10.1002/ajh.25288
- By:
- Publication type:
- Article
Associations between elevated pre-treatment serum cytokines and peripheral blood cellular markers of immunosuppression in patients with lymphoma.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 8, p. 752, doi. 10.1002/ajh.24758
- By:
- Publication type:
- Article
Early event status informs subsequent outcome in newly diagnosed follicular lymphoma.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 11, p. 1096, doi. 10.1002/ajh.24492
- By:
- Publication type:
- Article
Cytomegalovirus infection does not impact on survival or time to first treatment in patients with chronic lymphocytic leukemia.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 8, p. 776, doi. 10.1002/ajh.24403
- By:
- Publication type:
- Article
Personalized risk prediction for event-free survival at 24 months in patients with diffuse large B-cell lymphoma.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 2, p. 179, doi. 10.1002/ajh.24223
- By:
- Publication type:
- Article
Non- Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the National Cancer Data Base from 1998 to 2011.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 9, p. 790, doi. 10.1002/ajh.24086
- By:
- Publication type:
- Article
Elevated soluble IL-2 Rα, IL-8, and MIP-1β levels are associated with inferior outcome and are independent of MIPI score in patients with mantle cell lymphoma.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 12, p. E223, doi. 10.1002/ajh.23838
- By:
- Publication type:
- Article
Elevated monoclonal and polyclonal serum immunoglobulin free light chain as prognostic factors in B- and T-cell non- Hodgkin lymphoma.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 12, p. 1116, doi. 10.1002/ajh.23839
- By:
- Publication type:
- Article
Genetic polymorphisms in oxidative stress-related genes are associated with outcomes following treatment for aggressive B-cell non-Hodgkin lymphoma.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 6, p. 639, doi. 10.1002/ajh.23709
- By:
- Publication type:
- Article
Elevated serum monoclonal and polyclonal free light chains and interferon inducible protein-10 predicts inferior prognosis in untreated diffuse large B-cell lymphoma.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 4, p. 417, doi. 10.1002/ajh.23658
- By:
- Publication type:
- Article
A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and <sup>90</sup>yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphoma.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 7, p. 589, doi. 10.1002/ajh.23460
- By:
- Publication type:
- Article
Elevated pretreatment serum levels of interferon-inducible protein-10 (CXCL10) predict disease relapse and prognosis in diffuse large B-cell lymphoma patients.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 9, p. 865, doi. 10.1002/ajh.23259
- By:
- Publication type:
- Article
Germline variation in complement genes and event-free survival in follicular and diffuse large B-cell lymphoma.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 9, p. 880, doi. 10.1002/ajh.23273
- By:
- Publication type:
- Article
Inherited genetic variation and overall survival following follicular lymphoma.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 7, p. 724, doi. 10.1002/ajh.23184
- By:
- Publication type:
- Article
Elevated serum free light chains are associated with inferior event free and overall survival in Hodgkin lymphoma.
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 12, p. 998, doi. 10.1002/ajh.22168
- By:
- Publication type:
- Article
Complementary and alternative medicine use among long-term lymphoma survivors: A pilot study.
- Published in:
- American Journal of Hematology, 2009, v. 84, n. 12, p. 795, doi. 10.1002/ajh.21554
- By:
- Publication type:
- Article
Human Pegivirus Infection and Lymphoma Risk: A Systematic Review and Meta-analysis.
- Published in:
- Clinical Infectious Diseases, 2020, v. 71, n. 5, p. 1221, doi. 10.1093/cid/ciz940
- By:
- Publication type:
- Article
Engineering Rhodosporidium toruloides for increased lipid production.
- Published in:
- Biotechnology & Bioengineering, 2016, v. 113, n. 5, p. 1056, doi. 10.1002/bit.25864
- By:
- Publication type:
- Article
Degradation Signals for Ubiquitin-Proteasome Dependent Cytosolic Protein Quality Control (CytoQC) in Yeast.
- Published in:
- G3: Genes | Genomes | Genetics, 2016, v. 6, n. 7, p. 1853, doi. 10.1534/g3.116.027953
- By:
- Publication type:
- Article
MCL-042: Evolving Frontline Immunochemotherapy for Mantle Cell Lymphoma and the Impact on Survival Outcomes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S408, doi. 10.1016/S2152-2650(21)01919-4
- By:
- Publication type:
- Article
Poster: MCL-042: Evolving Frontline Immunochemotherapy for Mantle Cell Lymphoma and the Impact on Survival Outcomes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S246, doi. 10.1016/S2152-2650(21)01551-2
- By:
- Publication type:
- Article
Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01080-0
- By:
- Publication type:
- Article
Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort study.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00942-3
- By:
- Publication type:
- Article
T-cell phenotype including CD57<sup>+</sup> T follicular helper cells in the tumor microenvironment correlate with a poor outcome in follicular lymphoma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00899-3
- By:
- Publication type:
- Article
Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00847-1
- By:
- Publication type:
- Article
Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00847-1
- By:
- Publication type:
- Article
Efficacy of front-line immunochemotherapy for follicular lymphoma: a network meta-analysis of randomized controlled trials.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41408-021-00598-x
- By:
- Publication type:
- Article
Patterns of therapy initiation during the first decade for patients with follicular lymphoma who were observed at diagnosis in the rituximab era.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 7, p. 1, doi. 10.1038/s41408-021-00525-0
- By:
- Publication type:
- Article
JAK2 activation promotes tumorigenesis in ALK-negative anaplastic large cell lymphoma via regulating oncogenic STAT1-PVT1 lncRNA axis.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 11, p. 1, doi. 10.1038/s41408-020-00382-3
- By:
- Publication type:
- Article
High level MYC amplification in B-cell lymphomas: is it a marker of aggressive disease?
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41408-019-0271-z
- By:
- Publication type:
- Article
Amplification of 9p24.1 in diffuse large B-cell lymphoma identifies a unique subset of cases that resemble primary mediastinal large B-cell lymphoma.
- Published in:
- Blood Cancer Journal, 2019, v. 9, n. 9, p. N.PAG, doi. 10.1038/s41408-019-0233-5
- By:
- Publication type:
- Article
Association of elevated serumfree light chains with chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis.
- Published in:
- Blood Cancer Journal, 2019, v. 9, n. 8, p. N.PAG, doi. 10.1038/s41408-019-0220-x
- By:
- Publication type:
- Article
LESSONS LEARNED.
- Published in:
- Science & Children, 2010, v. 47, n. 9, p. 32
- By:
- Publication type:
- Article
Fluorodeoxyglucose‐Positron Emission Tomography Predicts Bone Marrow Involvement in the Staging of Follicular Lymphoma.
- Published in:
- Oncologist, 2020, v. 25, n. 8, p. 689, doi. 10.1634/theoncologist.2019-0952
- By:
- Publication type:
- Article
The Ratios of CD8<sup>+</sup> T Cells to CD4<sup>+</sup>CD25<sup>+</sup> FOXP3<sup>+</sup> and FOXP3<sup>-</sup> T Cells Correlate with Poor Clinical Outcome in Human Serous Ovarian Cancer.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0080063
- By:
- Publication type:
- Article